Background and Purpose-Single small subcortical infarctions (SSSIs), so-called lacunae, are typically caused by lipohyalinosis of a perforator artery. However, SSSIs can be caused by underlying large parent arterial disease or microatheroma of the proximal portion of a perforator artery. We sought to investigate whether indicators for small vessel disease (SVD) and atherosclerosis in patients with SSSI differ according to lesion location and the presence of parent artery disease. Methods-We assessed 449 patients who had an SSSI (lesion diameter Յ20 mm) in the perforator territory of middle cerebral artery (nϭ244), basilar artery (nϭ141), and vertebral artery (nϭ64) on diffusion-weighted imaging performed within 48 hours of stroke onset. We divided SSSI into 3 groups according to lesion location and the presence of parent artery disease: (1) SSSI with parent artery disease (SSSIϩPAD); (2) proximal SSSI without PAD (pSSSI-PAD); and (3) distal SSSI without PAD (dSSSI-PAD). The prevalence of SVD indicators (leukoaraiosis and microbleeds) and atherosclerosis indicators (cerebral atherosclerosis and coronary heart disease) were compared among the groups. Results-SSSIϩPAD had the highest prevalence of atherosclerosis indicators and the lowest prevalence of SVD indicators, whereas dSSSI-PAD had the lowest prevalence of atherosclerosis indicators and the highest prevalence of SVD indicators. pSSSI-PAD showed intermediate features. Atherosclerosis indicators significantly increased and SVD indicators significantly decreased as the vascular territory became lower (from middle cerebral artery, basilar artery to vertebral artery). Conclusion-Differences in SVD and atherosclerosis indicators suggest that SSSI has a heterogeneous pathogenesis according to lesion location and the presence of PAD.
S
ingle small subcortical infarctions (SSSIs) within the territory of a perforating artery, or lacunae, are usually caused by small vessel disease and are pathologically characterized by fibrinoid degeneration or lipohyalinosis. 1, 2 In some patients, however, SSSI may be caused by occlusion of the orifice of a perforator due to local thrombus formation at the stenotic segment of the parent artery. [3] [4] [5] [6] [7] SSSIs associated with parent artery disease have been shown to be located adjacent to the parent artery. 8 Moreover, in SSSIs without parent artery disease, the proximal portion of the perforating artery may be occluded by arteriosclerosis resulting in SSSI located in the proximal region near the parent artery, whereas the distal perforating artery may be afflicted by fibrinoid degeneration or lipohyalinosis [3] [4] [5] [6] [7] causing SSSI located in more distal region. Therefore, SSSIs may be divided into 3 categories: SSSI associated with parent artery disease (SSSIϩPAD), arteriosclerotic proximal perforator disease without PAD (pSSSI-PAD), and distal perforator disease without PAD (dSSSI-PAD; Figure 1 ).
Despite the previously mentioned differences, SSSI has been regarded as a homogeneous entity. Although efforts have been made to distinguish the differences, previous studies have not assessed the relationship between SSSI and PAD 9 -12 or have evaluated limited numbers of patients. 13 We hypothesized that atherosclerosis indicators such as a history of coronary heart disease or the presence of other asymptomatic cerebral arterial atherosclerosis (ACAS) are more prevalent in SSSIϩPAD, whereas leukoaraiosis and microbleeds, surrogate indicators of small vessel disease, 14 -17 are more prevalent in dSSSI-PAD and that pSSSI-PAD may show intermediate features. We also sought to determine whether the prevalence of indicators differs according to vascular territory, that is, the middle cerebral artery (MCA), basilar artery (BA), and vertebral artery (VA).
Methods
We retrospectively reviewed data from the prospectively collected stroke registry of Asan Medical Center. Consecutive patients who were admitted between March 2005 and December 2008 were considered if they had a unilateral SSSI (lesion diameter Յ20 mm) in the perforator territory of the MCA, BA, or VA on diffusionweighted imaging (DWI) performed within 48 hours of onset and underwent fluid-attenuated inversion recovery, gradient echo imaging, and MR angiography (MRA). BA perforator infarction was restricted to infarcts occurring in the paramedian pontine area. 18 More lateral infarcts in the area presumably supplied by circumferential branches or the anterior inferior cerebellar artery were excluded. VA perforator infarction was restricted to infarcts in the medial medulla because lateral medullary infarction is frequently associated with nonatherosclerotic dissection of the VA. 19, 20 Because medial medullary infarction is rare, 21 we extended the inclusion period to 2001 for patients with medial medullary infarction. We excluded patients in whom embolism was a likely mechanism for the stroke, patients with potential cardiac embolic sources (eg, atrial fibrillation, recent myocardial infarction, dilated cardiomyopathy, valvular heart disease, or infectious endocarditis), and those with significant (Ն50%) stenosis of the responsible extracranial large artery.
Demographic features and risk factors were recorded, including hypertension (defined as receiving medication for hypertension or blood pressure Ͼ140/90 mm Hg on repeated measurements), diabetes mellitus (defined as receiving medication for diabetes mellitus, fasting blood sugar Ն126 mg/dL, or 2-hour postprandial blood sugar Ն200 mg/dL), hyperlipidemia (defined as receiving cholesterolreducing agents or overnight fasting cholesterol level Ͼ200 mg/dL), current (current or quit smoking Ͻ6 months) cigarette smoking, history of stroke, and history of coronary heart disease. National Institutes of Health Stroke Scale (NIHSS) score was measured at the time of admission.
According to our departmental policy, all patients with acute stroke within 24 hours of onset had undergone MRI scans, including DWI, fluid-attenuated inversion recovery, gradient echo, and MRA. After March 2007, all patients with stroke within 7 days of onset underwent DWI, fluid-attenuated inversion recovery, gradient echo, and MRA. MRIs were performed using either a 1.5-T or a 3.0-T MR imaging unit. The most common MRI parameters for DWI (repetition time of 7500 ms, echo time of 84 ms, matrix number of 128ϫ128, and 2 b values of 0 and 1000 s/mm 2 ) were a slice thickness of 5 mm, interslice gap of 2 mm, 20 axial slices, and field of view of 250 mm. fluid-attenuated inversion recovery images were obtained using a fast-spin echo sequence with a repetition time/echo timeϭ11 000/140 ms, an inversion timeϭ2500 ms, and a 256ϫ128 matrix. The gradient echo parameters were 5-mm slice thickness, 2-mm interslice gap, 20 axial slices, 250-mm field of view, 400-ms repetition time, 30-ms echo time, 20°flip angle, and 256ϫ192 matrix. Common MRA parameters included a flip angle of 20, a matrix number of 512ϫ512, and a field of view of 250 mm. Three-dimensional time-of-flight MRA of the circle of Willis was performed with repetition time of 25 ms and echo time of 2 ms. Three-dimensional contrast-enhanced MRA from the aortic arch to the level of central skull base was performed after an intravenous bolus injection of 20 mL (3 to 4 mL/s) of gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany) with repetition time of 6 ms and echo time of 1 ms. The angiographic images of 3-dimensional time-of-flight and contrast-enhanced MRA were reconstructed with the maximum intensity projection algorithm.
The status of the parent artery was categorized as normal, mild (Ͻ50%) stenosis, and moderate to severe (Ͼ50% to occlusion) stenosis. In this study, stenosis of any degree was regarded as a significant cause of SSSI. 22 Concomitant ACAS, that is, any extracranial and intracranial cerebral artery atherosclerotic disease except for that related to current SSSI, was also assessed. The presence and the degree of vascular stenosis were decided by consensus among 3 physicians (2 stroke neurologists and 1 neuroradiologist) blinded to lesion location. Lesion location in relation to the parent artery was dichotomized as proximal (extending to the basal surface of the parent artery) and distal (not extending to the basal surface of the parent artery; Figures 1 and 2 ). In patients with BA and VA perforator infarctions, extension of each lesion to the basal surface was assessed by axial DWI. In patients with MCA perforator infarctions, involvement of the lowest portion of the basal ganglia was considered as an extension to the basal surface 23 ( Figure  2 ) because coronal MRI is not routinely performed in our institution. Based on fluid-attenuated inversion recovery imaging, leukoaraiosis was graded from 0 to 3 according to the Fazekas scale of deep white matter changes with scores of 2 and 3 considered significant leukoaraiosis. 24 Microbleeds were defined as unambiguous homogeneous round lesions with diameters Յ5 mm with signal loss as determined by gradient echo. 25 The presence and total number of microbleeds were recorded.
For statistics, differences in categorical variables were evaluated using the Pearson 2 test and trend analysis. Differences in continuous variables were evaluated using Student t test and analysis of variance test for age and Mann-Whitney U test and Kruskal-Wallis test for NIHSS, Fazekas grading scale, and number of microbleeds. All statistical analyses were performed using SPSS Version 14.0. A probability value Ͻ0.05 was considered statistically significant.
Results

General Patient Characteristics
During the study period, 2342 patients with acute ischemic stroke were registered and 805 patients had SSSI. Of them, 225 patients were excluded due to the imaging criteria (not undergoing MRI within 48 hours of onset or not undergoing the full-sequence MRI due to the aforementioned departmental policy). Fifty-nine patients with cardiac embolic sources, 53 with significant stenosis in the responsible extracranial artery, and 19 patients treated with thrombolytic agents were also excluded. Thus, our study cohort consisted of 449 patients (268 men, 181 women) with a mean age of 63.4Ϯ11.1 years (range, 24 to 96 years). Risk factors included hypertension in 369 patients (82%), diabetes in 175 (39%), cigarette smoking in 164 (37%), and hyperlipidemia in 202 (45%). One hundred thirteen (25%) patients had histories of stroke and 37 (8%) had histories of coronary heart disease. The median NIHSS score was 4 (interquartile range, 2 to 5). PAD was observed in 114 (25%) patients and concomitant ACAS in 162 (36%). Extension of the lesion to the basal surface of the parent artery was observed in 263 (59%) patients. Leukoaraiosis was observed in 159 (35%) patients and microbleeds in 121 (27%).
Characteristics of SSSI According to the Presence of PAD
Of the 449 patients, 114 patients had PAD (SSSIϩPAD) and 335 did not (Table 1 ). Most (89%) patients with SSSIϩPAD had pSSSI. Patients with SSSIϩPAD had a higher prevalence of coronary heart disease (Pϭ0.032) and ACAS (PϽ0.001) than those without PAD. The prevalence of dSSSI (PϽ0.001), leukoaraiosis (PϽ0.001), Fazekas Scale score (PϽ0.001), prevalence of microbleed (Pϭ0.001), and number of microbleeds (Pϭ0.001) were lower in patients with SSSIϩPAD than in those without PAD.
Characteristics of SSSI According to Lesion Location in Relation to the Parent Artery
Of the 335 patients without PAD, 162 had pSSSI and 173 had dSSSI. As shown in Table 2 , patients with dSSSI-PAD had a significantly higher prevalence of hypertension, leukoaraiosis, and microbleeds and a lower prevalence of diabetes and ACAS than those with pSSSI-PAD. When we compared dSSSI-PAD, pSSSI-PAD, and SSSIϩPAD groups together, there were significant differences in the prevalence of diabetes, ACAS, leukoaraiosis, and microbleeds (Table 3) .
Characteristics of SSSI According to Vascular Territory
Of the 449 patients, 244 had infarctions in the MCA perforator territory, 141 in the BA, and 64 in the VA territory. General characteristics, except for diabetes and a history of coronary heart disease, did not differ among the 3 groups (Table 4) . As the vascular territory got lower from the MCA, BA to VA, the followings were observed; the prevalence of dSSSI (lesion not extended to the basal surface) significantly decreased (PϽ0.001) and the prevalence of parent artery disease and ACAS significantly increased (PϽ0.001); the prevalence of leukoaraiosis was not different between the groups (Pϭ0.083) but showed a significant linear trend (Pϭ0.029) toward decrease; the mean Fazekas scores significantly decreased (Pϭ0.036); and the prevalence of microbleeds was not different between the groups (Pϭ0.096) but showed a significant linear trend (Pϭ0.040) toward decrease.
After excluding patients with PAD, there were 202 SSSIs in the MCA, 106 in the BA, and 27 SSSIs in the VA territory. Among these 3 groups, diabetes and pSSSI were more frequent as the vascular territory became lower. Moreover, there was a tendency for ACAS to increase and Fazekas grading scale to decrease as vascular territory got lower (Table 4) .
Discussion
Consistent with previous results, 8 we found that most patients with SSSIϩPAD had pSSSI, whereas only 11% had dSSSI. As expected, patients with SSSIϩPAD had a significantly higher prevalence of coronary heart disease and ACAS and a significantly lower prevalence of leukoaraiosis and microbleeds than those without PAD. We also found that dSSSI-PAD was closely associated with hypertension, leukoaraiosis, and microbleeds, whereas pSSSI-PAD was more frequently related to diabetes and a higher prevalence of ACAS. Because both diabetes and coronary heart disease are more prevalent in patients with large artery atherosclerosis than in those with small vessel disease, 26, 27 and leukoaraiosis and microbleeds are closely associated with small vessel disease, our results suggest that dSSSI-PAD is primarily caused by lipohyalinosis/fibrinoid degeneration, whereas pSSSI-PAD is more closely related to atherosclerosis. dSSSI associated with PAD might be a mixed type, but the small number of cases precludes an analysis of this type. Our results, therefore, illustrate that pathogenesis of SSSI may be heterogeneous depending on the presence of PAD and on lesion location in relation to the parent artery in patients without PAD. The results were similar when we limited the scope of the study to patients with MCA perforator infarction only (data not shown).
Our observation seems to agree with previous pathology studies. According to Fisher and Caplan, the orifices of the penetrating branch may be blocked by atheroma in the parent artery or microatheroma arising at the proximal portion of the branch itself. 3, 6 These so-called "intracranial branch atheromatous diseases" are distinguished from lipohyalinosis occurring in distal branches. Thus, intracranial branch atheromatous disease corresponds to SSSIϩPAD and pSSSI-PAD in our studies. Because we now can easily identify the presence of PAD and the location of infarcts by advanced imaging tools, dividing SSSIs into 3 categories, SSSIϩPAD, pSSSI-PAD, and dSSSI-PAD, based on imaging findings would be of value in clinical practice.
We also found that as the vascular territory became lower from the MCA to the VA, the prevalence of small vessel disease indicators decreased and the prevalence of atherosclerosis indicators increased. Because SSSIϩPAD is closely associated with atherosclerosis indicators, our results may be related in part to the increased prevalence of SSSIϩPAD in the VA and BA than in the MCA territory SSSIs (Table 4) . However, we also found that excluding the patients with parent artery disease, the incidence of dSSSI (versus pSSSI) was higher in MCA than in BA or VA territories, which may also explain the differences (Table 4) . Whatever the explanation, our data showed that characteristics of SSSI are heterogeneous according to the vessel territory as well.
Our study had several limitations. First, although we observed differences in atherosclerotic and small vessel disease indicators among the 3 patient groups, none of our patients was examined at autopsy. Thus, our findings provided circumstantial rather than direct evidence for different 
IQR indicates interquartile range.
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pathogeneses of SSSI. Second, although the parent artery revealed by MRA may look patent, we cannot rule out the presence of mild atherosclerotic plaque that does not induce significant luminal narrowing. However, because the purpose of our study was to classify different entities of SSSIs in a practical setting, this limitation was inevitable. Third, because we included patients with relatively acute (within 48 hours) infarction, we could not rule out that MRA lesions were due to a partial embolic occlusion. To overcome this problem, we excluded patients with potential embolic sources either from the heart or the proximal vessel. Moreover, according to previous studies, embolic MCA occlusion rarely causes SSSI if infarcts are assessed with DWI. 22, 28 Therefore, the possibility of embolic occlusion should be low, although this could not be completely ruled out. Finally, because the study design was retrospective, we could not address differences in the clinical course of SSSI relative to the different underlying pathologies. 11,22,29 -31 Further prospective studies are required to answer this important question. In summary, our data suggest that SSSI has a heterogeneous pathogenesis according to lesion location and the presence of PAD. Our results may have clinical implications. When encountering patients with SSSIϩPAD or pSSSI-PAD, physicians may have to be more alert for the presence of systemic atherosclerosis such as coronary heart disease. Antiatherosclerotic medications such as statins may be more efficacious in these patients than in those with dSSSI-PAD. In contrast, aggressive blood pressure management may be more important, and drugs inducing bleeding tendency (ie, dual antiplatelet agents) may have to be used more cautiously in patients with dSSSI-PAD than in those with pSSSI-PAD or SSSIϩPAD. These issues are currently being addressed by ongoing multicenter trials. 32, 33 
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